Default company panoramic image

Adherean Inc.

New MIT tech co Adherean uses novel health checkups to remotely reward healthy behavior. Annual per patient savings of $1,016 for HIV and Type II diabetes.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location Boston, MA, USA
  • Currency USD
  • Founded June 2011
  • Employees 7
  • Website

Company Summary

Emerging from MIT, Adherean Inc is a health services company centered on incentivizing patients to stay on track with their health. Adherean's work is enabled by its proprietary Healthcheck care management platform, which allows us to remotely collect direct clinical data on a wide array of patient health markers and medication levels, and can be used to reward patients for staying on track with their regimens.


  • Default avatar
    Josiah Seale

    Josiah Seale hails from Venezuela, with roots in a primary care / international development context. He has a professional background in early stage biotech firms and economic consulting for the healthcare/pharma sector. Josiah holds an MBA from the MIT Sloan Schol of Management with a focus in entrepreneurship & innovation, as well as undergraduate and master's degrees from MIT.

  • Default avatar
    Angela Kilby
    Co-Founder, Chief Economist

    Angela Kilby, of Houston TX, is a doctoral candidate in economics at MIT, where she is a National Science Foundation Fellow in the use of behavioral incentives to drive healthy behavior. Prior to MIT, Ms. Kilby worked as an economist for the MIT Jameel Poverty Action Lab, where she investigated the use of incentives in global health. In addition to her doctoral work, Ms. Kilby holds two other degrees from MIT and was a Luce Scholar in Indonesia.

  • Default avatar
    Brian Belmont, PhD
    Chief Scientific Officer

    As Adherean's CSO, Brian Belmont (of Allentown, Pennsylvania) has taken charge of opening the company's BSL2 facility and directing the biochemical work that allows Adherean to capture relevant clinical data. Brian's background is in functionalized assays and pharmaceutical development. He holds a PhD from MIT in Biological Engineering and an undergraduate degree from Stanford, where he served on the university's prize-winning solar car team.

  • Default avatar
    Dr. Amol Navathe, MD, PhD
    Chief Medical Officer

    Dr. Amol Navathe joins Adherean from the Obama administration, where he managed the $1.1 billion dollar comparative effectiveness portfolio at the Department of Health and Human Services. Hailing from Atlanta, GA, Dr. Navathe holds an MD from the University of Pennsylvania and a PhD in Health Economics from the Wharton School. He originally consulted for healthcare clients with McKinsey & Co, after receiving an engineering degree from Stanford.


  • Default avatar
    John Chory, Latham & Watkins
    Default avatar
    Joe Lazarek, Morris & Morris

Previous Investors

  • Default avatar
    Prof. Ed Roberts, MIT Sloan School of Management & Board of Directors, Daktari Diagnostics